The National Cancer Data Base report on colon cancer

Cancer

Volumn 78, Issue 4, 1996, Pages 918-926

  Jessup, J Milbum ^a,c   McGinnis, Lamar S ^b,d,e   Steele Jr , Glenn D ^f   Menck, Herman R ^a   Winchester, David P ^a,g,h  

^a AMERICAN COLLEGE OF SURGEONS   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DeKalb Medical Center   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g EVANSTON HOSPITAL   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

colon cancer; National Cancer Data Base; outcome; treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; DATA BASE; EARLY DIAGNOSIS; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; EPIDEMIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; UNITED STATES;

EID: 0029737661     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960815)78:4<918::AID-CNCR32>3.0.CO;2-W     Document Type: Article

References (51)

1. Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP. National Cancer Data Base: Annual Review of Patient Care, 1995, Atlanta: American Cancer Society, 1995.
2. American Cancer Society. Cancer Facts and Figures-1995. Atlanta: American Cancer Society, 1993.
3. Steele GD Jr. The surgical oncologist as a key translator of basic biology to patients with GI cancer: asking the right questions. Ann Surg Oncol 1994;1:262-9.
4. Evans JT, Vana J, Aronoff BL. Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg 1978;188:716-20.
5. Beart RW, Steele GD, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg 1995;181:225-36.
6. Beart RW. Colon Cancer. In: Steele GD, Winchester DP, Menck HR, Murphy GP, editors. National Cancer Data Base: Annual Review of Patient Care, 1992. Atlanta: American Cancer Society, 1992:40-46.
7. Steele, GD. Colorectal Cancer. In: Steele GD, Winchester DP, Menck HR, Murphy GP, editors. National Cancer Data Base Annual Review of Patient Care, 1993. Atlanta: American Cancer Society, 1993:20-36.
8. Steele GD. The National Cancer Data Base report on colo-rectal cancer. Cancer 1994;74:1979-89.
9. Steele GD, Jessup JM. Colorectal Cancer. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, editors. National Cancer Data Base Annual Review of Patient Care, 1995. Atlanta: American Cancer Society, 1995:66-83.
10. Jessup JM, Steele GD, Winchester DP. Introduction. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, editors. National Cancer Data Base Annual Review of Patient Care, 1995. Atlanta: American Cancer Society, 1995: 1-11.
11. International Classification of Diseases for Oncology. 2nd ed. Geneva: World Health Organization, 1992.
12. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for Staging of Cancer. 4th ed. Philadelphia: JB Lippincott, 1992.
13. Steele GD Jr., Augenblick LH, Begg CB. National Institutes of Health Consensus Development Conference Statement - Adjuvant therapy for patients with Colon and Rectal Cancer. JAMA 1990;264:1444-50.
14. Laurie JA, Moertel CG, Fleming TR. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and combination of levamisole and fluorouracil. J Clin Oncol 198;7:1447-56.
15. Moertel CG, Fleming TR, MacDonald JS. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
16. Ries LAG, Miller BA, Hankey BF, Cosary CL, Harras A, Edwards BK. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Bethesda (MD): National Cancer Institute; 1994. Report No.: NIH-94-2789.
17. D'Onofrio GMD, Tan EGC. Is colorectal carcinoma in the young a more deadly disease? Aust N Z J Surg 1985;55:537-40.
18. Payne JE, Chapuis PH, Pheils MT. Surgery for large bowel cancer in people aged 75 years and older. Dis Colon Rectum 1986;29:733-7.
19. Wise WE, Padmanabhan A, Meesig DM. Abdominal colon and rectal operations in the elderly. Dis Colon Rectum 1991;34:959-63.
20. Hobler KE. Colon surgery for cancer in the very elderly: cost and 3-year survival. Ann Surg 1986;203:129-31.
21. Arnaud JP, Schloegel M, Oilier JC. Colorectal cancer in patients over 80 years of age. Dis Colon Rectum 1991;34:896-8.
22. Adloff M, Arnaud JP, Schloegel M. Colorectal cancer in patients under 40 years of age. Dis Colon Rectum 1986;29:322-5.
23. Thomas CR Jr., Gale M, Evans N, Editors. Racial differences in the incidence of colon and rectal cancer in patients under the age of forty. Proceedings of the Third International Conference on Anticancer Research; 1990; .
24. Boring CC, Squires TS, Heath CW Jr. Cancer statistics for African Americans. Cancer 1992;42:7-17.
25. Weaver P, Harrison B, Eskander G. Colon cancer in blacks: a disease with worsening prognosis. J Natl Med Assoc 1991; 83:133-6.
26. Hermanek P, Sobin LH. TNM: Classification of Malignant Tumours. 4th ed. Berlin: Springer-Verlag, 1987:47-50.
27. Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437-59.
28. Dukes CE. The classification of cancer of the rectum. J Pathol Bact 1932;35:323-32.
29. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look following "curative surgery" for adenocarcinoma of the rectum. Cancer 1974;34:1278-92.
30. Astler VB, Coller FA. Prognostic significance of direct extension of carcinoma of colon and rectum. Ann Surg 1954; 139:846-52.
31. Jass JR. The pathological grading and staging of rectal cancer. Scand J Gastroenterol Suppl 1988;149:21-38.
32. Bjerkeset T, Morild I, Mork S, Soreide O. Tumor characteristics in colorectal cancer and their relationship to treatment and prognosis. Dis Colon Rectum 1987;30(12):934-8.
33. Halvorsen TB, Seim E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J Clin Pathol 1988;41:1068-72.
34. Stahle E, Glimelius B, Bergstrom R, Pahlman L. Preoperative clinical and pathological variables in prognostic evaluation of patients with rectal cancer. A prospective study of 327 consecutive patients. Acta Chir Scand 1988;154:231-9.
35. Fisher ER, Robinsky B, Sass R, Fisher B. Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Dis Colon Rectum 1989; 32:944-9.
36. Grinnell RS. The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 1939;109:500-33.
37. Spratt JS. Jr., Spjut HJ. Prevalance and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer 1967;20:1976-85.
38. Symonds DA, Vicery AL. Mucinous carcinoma of the colon and rectum. Cancer 1979;37:1891-1900.
39. Kokal WA, Gardine RL, Sheibani K, Morris PL, Prager E, Zak IW, et al. Tumor DNA content in resectable, primary colorectal carcinoma. Ann Surg 1989;209:188-93.
40. Tomoda H, Kakeji Y, Furusawa M. Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study. J Surg Oncol 1993;53:144-8.
41. Schillaci A, Tirindelli DD, Ferri M, Teodori L, Mauro F, Nicolanti V, Stipa S. Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content. Int J Colorectal Dis 1990;5:223-7.
42. Murray D, Hreno A, Dutton J. Prognosis in colon cancer: a pathologic reassessment. Arch Surg 1975;110:908-13.
43. Godwin JD II, Brown CC. Some prognostic factors in survival of patients with cancer of the colon and rectum. J Chron Dis 1975;28:441-5.
44. Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 1984;2:733-6.
45. Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer 1988;61:1417-24.
46. Jass JR, Mukawa K, Goh HS, Love SB, Capellaro D. Clinical importance of DNA content in rectal cancer measured by flow cytometry. J Clin Pathol 1989;42:254-9.
47. Chapuis PH, Dent OF, Fisher R. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
48. Steinberg SM, Barkin JS, Kaplan RS. Prognostic indicators of colon tumors: The Gastrointestinal Tumor Group experience. Cancer 1986;57:1866-70.
49. Phillips RKS, Hittinger R, Blesovsky L. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg 1984;71:604-10.
50. Davis NC, Newland RC. The reporting of colorectal cancer: the Australian clinico-pathological staging system. Aust N Z J Surg 1982;52:395-7.
51. deMello J, Struthers L, Turner R. Multivariate analysis as aides to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer 1983;48:341-8.